TSBX NASDAQ
Turnstone Biologics Corp.
1W: +1.1%
1M: -3.6%
3M: +4.4%
1Y: -83.6%
$0.35
Last traded 2025-08-11 — delisted
Overview
News
Chart
Smart Money
Financials
Income Statement
Cash Flow
Balance Sheet
Earnings
Dividends
Analysis
Technicals
Weather
Peers
ESG
Institutions
Dark Pool
Short Interest
Supply Chain
Income Trends
Revenue
$0
-100.0% ▼
Gross Profit
-$2M
-111.1% ▼
Operating Income
-$72M
-24.7% ▼
Net Income
-$71M
-28.3% ▼
EPS (Diluted)
$-3.07
-12.5% ▼
EBITDA
-$69M
-22.6% ▼
Profit Margins
Year-over-Year Growth
View Full Income Statement
| Line Item | FY2021 | FY2022 | FY2023 | FY2024 |
|---|---|---|---|---|
| Revenue | $101M | $73M | $19M | $0 |
| YoY Growth | +0.0% | -27.6% | -73.7% | -100.0% |
| Cost of Revenue | $2M | $2M | $3M | $2M |
| Gross Profit | $99M | $71M | $17M | -$2M |
| Gross Margin | 98.0% | 97.0% | 85.5% | — |
| R&D Expenses | $53M | $85M | $60M | $56M |
| SG&A Expenses | $14M | $18M | $18M | $16M |
| Operating Expenses | $66M | $103M | $75M | $71M |
| Operating Income | $33M | -$32M | -$58M | -$72M |
| Operating Margin | 32.6% | -43.1% | -301.1% | — |
| Interest Expense | $0 | $0 | $0 | $0 |
| Income Before Tax | $34M | -$31M | -$55M | -$71M |
| Tax Expense | $432K | $141K | -$286K | $37K |
| Net Income | $33M | -$31M | -$55M | -$71M |
| Net Margin | 32.8% | -42.1% | -285.9% | — |
| EPS (Diluted) | $1.50 | $-1.39 | $-2.73 | $-3.07 |
| EBITDA | $36M | -$28M | -$56M | -$69M |
| Shares Outstanding | 22M | 22M | 20M | 23M |